Todd Edwards

7PUBLICATIONS
109CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 19, 2024
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers.

Young Kwang Chae, Lucy Corthell, Sandip Pravin Patel

|Jul 01, 2024
NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs.

Bowen Dong, Nataša Obermajer, Takemasa Tsuji

|Feb 16, 2023
Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy.

Alexander J Cole, Santiago Panesso-Gómez, Jaynish S Shah

|Jan 20, 2022
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity.

Brian Orr, Haider Mahdi, Yusi Fang

|Nov 04, 2020
Cross-Cancer Genome-Wide Association Study of Endometrial Cancer and Epithelial Ovarian Cancer Identifies Genetic Risk Regions Associated with Risk of Both Cancers.

Dylan M Glubb, Deborah J Thompson, Katja K H Aben

Pageof 2